Dr. Nirni Sharanabasappa Somanath

Dr. Nirni Sharanabasappa Somanath
Medical Oncologist, Hyderabad

MBBS, MD (Internal Medicine), DM (Haemato-Oncology)

  • 1 Hospital
  • Worked as consultant Medical Oncologist and Hematologist at Apollo Cancer Hospital, Hyderabad(350 bedded super specialty Hospital for 2 years)
  • Worked as Observer in Bone Marrow Transplant unit at St. Vincent Hospital (New York Medical School) New York
  • Worked as clinical observer in Bone Marrow Transplant unit at Queen’s Elizabeth Hospital, Birmingham – U.K 
  • Presently working as Senior Medical Oncologist & Hematologist at Indo American Cancer Institute & Research Centre, Hyderabad (350 bedded Cancer Hospital)
  • Worked as Senior Registrar in Medical oncology Department ICU in Jaslok Hospital and Research Center Mumbai for 6 months.
  • Worked as Senior Registrar in Medical ICU in Leelavati Hospital and Research Center Mumbai for 6 months
  • Worked as Registrar in Department of Medical oncology in Kidwai Memorial Institute of Oncology Bangalore for 3 months.
  • Worked as Medical assistant in Kasturba Infectious Disease Hospital Mumbai for 1 year

Specialities

  • Medical Oncology

  • Hemato Oncology

Expertise

Education

  • MBBS  From M.R. Medical College, Gulbarga University. Gulbarga Karnataka, India
  • MD (Internal Medicine) from M.R. Medical College, Gulbarga University. Gulbarga Karnataka, India
  • DM (Haemato – Oncology) from Gujarat Cancer and Research Institute, Gujarat University. Ahmedabad, Gujarat, India

Practice Information

Omega Hospitals, Hyderabad

Omega Hospitals, Hyderabad

MLA Colony Main Raod, Road No - 12, Banjara Hills, Hyderabad, Telangana - 500034

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Nirni Sharanabasappa Somanath and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • INTERNATIONAL DRUG TRAIL:GEMCITE + PACLITAXOL Vs PACLITAXOL in metastatic breast cancer
  • Study of two different dosing regimens of Capecitabine in Combination with intravenous Docetaxel in metastatic Breast Cancer
  • Ovarian Cancer Phase II US FDA Study , Co-Investigator 3
  • NSCLC Phase III US FDA Study , Co-Investigator 
  • Chemotherapy Induced Nausea & Vomiting , Phase III , US FDA Study – Principal Investigator 
  • Chemotherapy Induced Neutropenia, Phase III Study, Principal Investigator
  • “Use of Intravasular devices and its complication” at ASCO PAN ASIA Conference in February 2002 in New Delhi
  • “Study of Concurrent CT/RT with RT in locally advanced Nasopharyngeal cancer” at National conference of cancer & Research held at Trivendrum in January 2003
  • “Study of Rhabdomyosarcoma a GCRI experience” at National Conference of Pediatric Oncology in Ahmedabad in August 2002
  • “Study of Osteosarcoma a GCRI experience” at National Conference of Pediatric Oncology in Ahmedabad in August 2002
  • “Clinical Study and Recent advances in CML” at Annual conference of Gujarat Physician Association, in Ahmedabad August 2001
  • Indian Society of Medical and Pediatric Oncology
  • Association of Physician of India